About this trial
The goal of this clinical trial is to investigate the effects of acute passive continuous hypoxemia (simulated high-altitude at rest) on appetite and energy intake in healthy young female adults. The main questions it aims to answer are:
* Does six hours of simulated high-altitude (5000 meters) reduce scores of subjective appetite and energy intake? * Do changes in appetite and energy intake persist in the hours following the end of hypoxic exposure? Researchers will compare the effects of simulated high-altitude to a control normoxia (sea-level) condition to see if exposure to low oxygen levels independently affect appetite and energy intake.
Participants will:
* Visit the laboratory for a preliminary screening session to assess eligibility. * Undergo two randomized, single-blind, experimental sessions consisting of six hours of passive exposure to normoxia or hypoxia in a climate-controlled chamber. * Consume foods provided from a curated list, served in ad libitum quantities, after leaving the laboratory to assess post-exposure energy intake.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
English or French speaking
Ability to provide informed consent
Disqualifiers
History or evidence of chronic disease
Current use of hypolipemic medication
Current use of hormonal contraceptives
Current use of antidepressants
Trial design
Crossover
Treatments tested in this trial
Normoxia
Other interventionParticipants will undergo a 6-hour passive exposure to normoxia in a climate-controlled environmental chamber maintained at 22°C with 30% relative humidity. They will remain in a fasted state throughout the exposure period.
Hypoxia (simulated altitude of 5000 meters above sea-level)
Other interventionParticipants will undergo a 6-hour passive exposure to a simulated altitude of 5000 meters above sea-level in a climate-controlled environmental chamber maintained at 22°C with 30% relative humidity. They will remain in a fasted state throughout the exposure period.
Treatment groups
Trial outcomes
Primary outcomes
Change from baseline in desire to eat
Scores of subjective desire to eat, measured using visual analog scales. Measurements are performed upon arrival at the laboratory (baseline), hourly during the exposure, immediately after a 30-minute ad libitum buffet, immediately before bedtime, and 24 hours after the baseline measurement.
Change from baseline in hunger
Scores of subjective hunger, measured using visual analog scales. Measurements are performed upon arrival at the laboratory (baseline), hourly during the exposure, immediately after a 30-minute ad libitum buffet, immediately before bedtime, and 24 hours after the baseline measurement.
Change from baseline in fullness
Scores of subjective fullness, measured using visual analog scales. Measurements are performed upon arrival at the laboratory (baseline), hourly during the exposure, immediately after a 30-minute ad libitum buffet, immediately before bedtime, and 24 hours after the baseline measurement.
Change from baseline in prospective food consumption
Scores of subjective prospective food consumption, measured using visual analog scales. Measurements are performed upon arrival at the laboratory (baseline), hourly during the exposure, immediately after a 30-minute ad libitum buffet, immediately before bedtime, and 24 hours after the baseline measurement.
Secondary outcomes
Heart rate
Measured continuously throughout the exposure.
Oxyhemoglobin saturation
Measured continuously throughout the exposure.
Systolic blood pressure
Measured upon arrival at the laboratory (baseline), hourly during the exposure, and immediately after eating.
Diastolic blood pressure
Measured upon arrival at the laboratory (baseline), hourly during the exposure, and immediately after eating.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Ottawa
Lead sponsor
Natural Sciences and Engineering Research Council, Canada
Collaborator
Hopital Montfort
Collaborator
Institut du Savoir Montfort
Collaborator